IVUS-OCT Integrated System Industry Report: 2026–2032 CAGR of 18.6%

I. Introduction

IVUS (Intravascular Ultrasound) and OCT (Optical Coherence Tomography) integrated systems, as advanced equipment in cardiovascular interventional diagnostics and treatment, combine the advantages of both imaging technologies. They provide clinicians with more precise information on vascular internal structures and lesions, holding significant value in clinical applications. This report conducts a comprehensive and in-depth analysis of the industry based on YHResearch survey data and explores investment opportunities.

II. Market Trend Evolution

(1) Significant Market Growth

According to YHResearch statistics, the global IVUS-OCT integrated system revenue reached approximately RMB 228 million in 2025 and is projected to approach RMB 836 million by 2032, with a CAGR of 18.6% from 2026 to 2032. This data indicates the industry is in a rapid growth phase with expanding market demand. With the rising incidence of cardiovascular diseases globally, the demand for precise diagnosis and treatment has become increasingly urgent. Leveraging its unique advantages, the IVUS-OCT integrated system has emerged as a vital tool in cardiovascular interventional diagnostics and therapy, driving sustained market expansion.

(2) Technological Convergence Fuels Market Development

The integration of IVUS and OCT technologies represents a key trend in this industry's evolution. IVUS provides depth information of the vessel wall, while OCT offers high resolution to clearly display the minute structures of the intravascular surface. The emergence of integrated systems combines the strengths of both technologies, providing physicians with more comprehensive vascular information. This aids in more accurate diagnosis of lesions, formulation of treatment plans, and evaluation of treatment outcomes. This technological convergence not only enhances the accuracy and safety of diagnosis and treatment but also meets the clinical demand for more precise medicine, further driving market development.

(3) Significant Potential in Emerging Markets

Beyond developed markets like Europe and the Americas, demand for IVUS-OCT integrated systems is steadily growing in emerging regions such as Asia-Pacific and Latin America. Economic development, rising healthcare standards, and heightened public health awareness in these areas are continuously unlocking demand for cardiovascular disease diagnosis and treatment. Simultaneously, the gradual improvement of medical infrastructure in emerging market nations provides the conditions for the widespread adoption and application of IVUS-OCT integrated systems, positioning these markets as a key driver for future industry growth.

III. Core Competitors' Strategic Layout

(1) International Giants Dominate the Market

Currently, the global IVUS-OCT integrated system market is primarily dominated by several international medical device giants. These companies hold significant market share globally, leveraging their robust R&D capabilities, extensive product portfolios, and broad sales networks. For instance, some firms continuously enhance product performance through sustained R&D investment, improving imaging quality and operational convenience. Simultaneously, they actively expand their global market footprint by establishing long-term partnerships with local medical institutions and distributors to broaden market share.

(2) Accelerated Rise of Domestic Players

In recent years, certain domestic medical device companies have intensified R&D investments in the IVUS-OCT integrated system sector, gradually gaining prominence. Domestic companies possess the advantage of proximity to the local market, enabling them to better understand the needs of domestic medical institutions and patients, and develop products more suited to the domestic market. At the same time, domestic companies also have certain advantages in cost control and after-sales service. By providing cost-effective products and high-quality after-sales service, they are gradually expanding their market share. Some domestic companies are also actively engaging in international cooperation, introducing advanced technologies and experience to enhance their competitiveness.

(3) Frequent Strategic Alliances and Collaborations

To enhance competitiveness, core competitors frequently form strategic alliances and collaborations. On one hand, companies engage in technical cooperation to jointly develop new products, achieving technology sharing and complementary strengths. On the other hand, they pursue market collaborations to expand sales channels and jointly develop markets. For example, some companies partner with research institutions to conduct clinical studies, providing scientific basis for product development and promotion. Others collaborate with distributors to establish joint marketing teams, increasing product market coverage.

IV. Characteristics of Supply Chain Structure

(1) Stable Upstream Raw Material Supply

Upstream raw materials for IVUS-OCT integrated systems primarily include optical components, electronic components, and mechanical parts. Globally, the supply of these materials remains relatively stable, though certain high-end materials still rely on imports. With the development of domestic industries, some local enterprises have achieved breakthroughs in raw material supply, enabling them to provide key components and reduce import dependency.

(2) Concentrated Midstream Manufacturing

Midstream production is concentrated among a few enterprises equipped with advanced manufacturing facilities and processes, ensuring product quality and consistency. The manufacturing process demands stringent environmental and technical standards, requiring rigorous quality control systems and production protocols. Some enterprises have enhanced efficiency and product quality by establishing modern production bases and implementing advanced production management systems.

(III) Diversified Downstream Sales Channels

Downstream sales channels primarily encompass medical institutions, distributors, and e-commerce platforms. Medical institutions serve as the primary users and purchasers of products, demanding high performance and quality standards. Distributors play a vital bridging role in product sales, facilitating broader market penetration. In recent years, with the growth of e-commerce, some enterprises have expanded their sales channels by selling products through online platforms.